======= HOXA5 ======= == Gene Information == * **Official Symbol**: HOXA5 * **Official Name**: homeobox A5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3202|3202]] * **UniProt**: [[https://www.uniprot.org/uniprot/P20719|P20719]] * **Interactions**: [[https://thebiogrid.org/search.php?search=HOXA5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20HOXA5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/142952|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Also binds to its own promoter. Binds specifically to the motif 5'-CYYNATTA[TG]Y-3'. |Homeobox| |cell-cell signaling involved in mammary gland development| |bronchiole development| |lung goblet cell differentiation| |intestinal epithelial cell maturation| |lobar bronchus epithelium development| |trachea cartilage morphogenesis| |lobar bronchus development| |columnar/cuboidal epithelial cell maturation| |trachea cartilage development| |lung-associated mesenchyme development| |mesenchymal-epithelial cell signaling| |lung secretory cell differentiation| |negative regulation of erythrocyte differentiation| |bronchus development| |intestinal epithelial cell development| |trachea morphogenesis| |respiratory system process| |positive regulation of receptor biosynthetic process| |epithelial cell maturation| |mammary gland epithelial cell differentiation| |regulation of mammary gland epithelial cell proliferation| |mammary gland lobule development| |mammary gland alveolus development| |trachea development| |lung epithelial cell differentiation| |intestinal epithelial cell differentiation| |lung cell differentiation| |thyroid gland development| |regulation of receptor biosynthetic process| |epithelial tube branching involved in lung morphogenesis| |cartilage morphogenesis| |lung epithelium development| |glandular epithelial cell differentiation| |lung alveolus development| |respiratory gaseous exchange by respiratory system| |lung morphogenesis| |regulation of erythrocyte differentiation| |columnar/cuboidal epithelial cell development| |mammary gland epithelium development| |negative regulation of myeloid cell differentiation| |multicellular organism growth| |positive regulation of myeloid cell differentiation| |embryonic skeletal system morphogenesis| |columnar/cuboidal epithelial cell differentiation| |RNA polymerase II distal enhancer sequence-specific DNA binding| |negative regulation of angiogenesis| |negative regulation of blood vessel morphogenesis| |negative regulation of vasculature development| |endocrine system development| |embryonic skeletal system development| |mammary gland development| |digestive tract development| |branching morphogenesis of an epithelial tube| |anatomical structure maturation| |negative regulation of hemopoiesis| |digestive system development| |cell maturation| |morphogenesis of a branching epithelium| |morphogenesis of a branching structure| |lung development| |cartilage development| |respiratory tube development| |positive regulation of hemopoiesis| |epithelial cell development| |respiratory system development| |anterior/posterior pattern specification| |mesenchyme development| |connective tissue development| |regulation of myeloid cell differentiation| |skeletal system morphogenesis| |developmental maturation| |regulation of angiogenesis| |embryonic organ morphogenesis| |epithelial tube morphogenesis| |regulation of vasculature development| |regionalization| |regulation of epithelial cell proliferation| |developmental growth| |growth| |gland development| |morphogenesis of an epithelium| |embryonic organ development| |pattern specification process| |negative regulation of immune system process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |regulation of hemopoiesis| |skeletal system development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |tissue morphogenesis| |embryonic morphogenesis| |chordate embryonic development| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |embryo development ending in birth or egg hatching| |tube morphogenesis| |DNA-binding transcription factor activity| |epithelial cell differentiation| |positive regulation of cell death| |negative regulation of cell differentiation| |tube development| |negative regulation of developmental process| |animal organ morphogenesis| |cell migration| |positive regulation of cell differentiation| |embryo development| |regulation of anatomical structure morphogenesis| |cell motility| |localization of cell| |epithelium development| |cell-cell signaling| |positive regulation of immune system process| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |locomotion| |positive regulation of developmental process| |DNA binding| |positive regulation of transcription, DNA-templated| |regulation of apoptotic process| |movement of cell or subcellular component| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |regulation of cell population proliferation| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |regulation of immune system process| |regulation of cell death| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |tissue development| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |system process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp533|TNF-alpha 44ng/ml R08 exp533]]|-2.06| |[[:results:exp93|DABN racemic mixture R03 exp93]]|1.91| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|2.19| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|2.26| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.75| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.99| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|3.21| |[[:results:exp33|Rotenone 2μM R00 exp33]]|3.83| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9832 * **Expression level (log2 read counts)**: -3.51 {{:chemogenomics:nalm6 dist.png?nolink |}}